Top Markets
Coin of the day
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Kedudukan dalam Saham #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Harga Saham
$1.81
Disegerakkan terakhir: 2026-08-21
Modal Pasaran
$77.00M
Perubahan (1 hari)
1.30%
Perubahan (1 tahun)
-23.63%
Negara
US
Perdagangan Annovis Bio, Inc. (ANVS)

Kategori

Sejarah harga saham bagi Annovis Bio, Inc. (ANVS)
Harga penutupan tertinggi: $1.82 pada 2026-08-01

Harga penutupan terendah: $7.71 pada 2020-01-01
Sejarah harga saham Annovis Bio, Inc. dari 2020 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -38.81%
2025 -26.28%
2024 -55.51%
2023 0.70%
2022 -41.39%
2021 233.32%
2020 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH